Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic

Immune responses to malignancies

(2010) Theresa L. Whiteside   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

(2009) M Czystowska et al.   CELL DEATH AND DIFFERENTIATION

Targeting the Immune System in Cancer

(2009) Devyani Chaudhuri et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes

(2009) E. U. Wieckowski et al.   JOURNAL OF IMMUNOLOGY

Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

(2008) Tianqian Zhang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression

(2008) Christoph Bergmann et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK